These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 18054939
1. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study. Ilveskoski E, Viiri LE, Mikkelsson J, Pörsti I, Lehtimäki T, Karhunen PJ. Atherosclerosis; 2008 Aug; 199(2):445-50. PubMed ID: 18054939 [Abstract] [Full Text] [Related]
4. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes. Jaakkola U, Kakko T, Seppälä H, Vainio-Jylhä E, Vahlberg T, Raitakari OT, Kallio J. Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708 [Abstract] [Full Text] [Related]
5. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD. Salminen M, Lehtimäki T, Fan YM, Vahlberg T, Kivelä SL. Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562 [Abstract] [Full Text] [Related]
6. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting. Pesonen U, Koch W, Schömig A, Kastrati A. J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169 [Abstract] [Full Text] [Related]
7. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. Erkkilä AT, Lindi V, Lehto S, Laakso M, Uusitupa MI. Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038 [Abstract] [Full Text] [Related]
13. Neuropeptide Y Leu7Pro polymorphism associated with the metabolic syndrome and its features in patients with coronary artery disease. Masoudi-Kazemabad A, Jamialahmadi K, Moohebati M, Mojarrad M, Manshadi RD, Akhlaghi S, Ferns GA, Ghayour-Mobarhan M. Angiology; 2013 Jan; 64(1):40-5. PubMed ID: 22308535 [Abstract] [Full Text] [Related]
14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly. Mikkelsson J, Perola M, Wartiovaara U, Peltonen L, Palotie A, Penttilä A, Karhunen PJ. Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474 [Abstract] [Full Text] [Related]
15. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY. Kallio J, Pesonen U, Karvonen MK, Kojima M, Hosoda H, Kangawa K, Koulu M. J Clin Endocrinol Metab; 2001 Nov; 86(11):5348-52. PubMed ID: 11701704 [Abstract] [Full Text] [Related]
17. Association of the endothelial nitric oxide synthase gene polymorphism with risk of coronary artery disease and myocardial infarction in middle-aged men. Kunnas TA, Ilveskoski E, Niskakangas T, Laippala P, Kajander OA, Mikkelsson J, Goebeler S, Penttilä A, Perola M, Nikkari ST, Karhunen PJ. J Mol Med (Berl); 2002 Sep; 80(9):605-9. PubMed ID: 12226742 [Abstract] [Full Text] [Related]
18. Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study. Hernesniemi JA, Karhunen PJ, Oksala N, Kähönen M, Levula M, Rontu R, Ilveskoski E, Kajander O, Goebeler S, Viiri LE, Hurme M, Lehtimäki T. Eur Heart J; 2009 Dec; 30(23):2939-46. PubMed ID: 19687159 [Abstract] [Full Text] [Related]
20. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects--the cardiovascular risk in young Finns study. Jaakkola U, Kakko T, Juonala M, Lehtimäki T, Viikari J, Jääskeläinen AE, Mononen N, Kähönen M, Koskinen T, Keltikangas-Järvinen L, Raitakari O, Kallio J. Neuropeptides; 2012 Dec; 46(6):321-8. PubMed ID: 23122776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]